Search
for
Sort by
Research 601–630 of 1000+
- Safety of testosterone use in women
- Selective non-steroidal inhibitors of 5α-reductase type 1
- Differential Suppression of Testosterone and Estradiol in Hirsute Women With the Superactive Gonadotropin-Releasing Hormone Agonist Leuprolide*
- Prevalence of androgenic alopecia in patients with polycystic ovary syndrome and characterization of associated clinical and biochemical features
- Polycystic Ovary Syndrome: A Common But Often Unrecognized Condition
- Neuroimmunoregulation of Androgens in the Adrenal Gland and the Skin
- Adult female acne and associated risk factors: Results of a multicenter case-control study in Italy
- Testosterone therapy for sexual dysfunction in postmenopausal women
- Clinical application of 5α-reductase inhibitors
- Endocrine-skin interactions
- Biology of Hair Growth
- Diagnostic Criteria for Polycystic Ovarian Syndrome
- Ornithine decarboxylase is upregulated by the androgen receptor in skeletal muscle and regulates myoblast proliferation
- Acanthosis nigricans, insulin resistance and cutaneous virilism
- Evidence-based approach to cutaneous hyperandrogenism in women
- Mood disorders and quality of life in polycystic ovary syndrome
- Non-classic congenital adrenal hyperplasia
- Polycystic Ovary Syndrome and Its Differential Diagnosis
- Hair removal in hirsute women with normal testosterone levels: a randomized controlled trial of long-pulsed diode laser vs. intense pulsed light
- Direct-Acting Vasodilators
- Polycystic ovary syndrome (PCOS)
- Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare
- Tissue insulin sensitivity and body weight in polycystic ovary syndrome
- Antiandrogens: Clinical applications
- An Update on Plant Derived Anti-Androgens
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome
- Prevalence of Polycystic Ovary Syndrome in Girls Aged 14–18 Years in Isfahan, Iran
- Local and Systemic Reduction by Topical Finasteride or Flutamide of Hamster Flank Organ Size and Enzyme Activity